Literature DB >> 22021336

The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury.

Manuela Funke1, Zhenwen Zhao, Yan Xu, Jerold Chun, Andrew M Tager.   

Abstract

Increased epithelial cell apoptosis in response to lung injury has been implicated in the development of idiopathic pulmonary fibrosis (IPF), but the molecular pathways promoting epithelial cell apoptosis in this disease have yet to be fully identified. Lysophosphatidic acid (LPA), which we have previously demonstrated to mediate bleomycin lung injury-induced fibroblast recruitment and vascular leak in mice and fibroblast recruitment in patients with IPF, is an important regulator of survival and apoptosis in many cell types. We now show that LPA signaling through its receptor LPA(1) promotes epithelial cell apoptosis induced by bleomycin injury. The number of apoptotic cells present in the alveolar and bronchial epithelia of LPA(1)-deficient mice was significantly reduced compared with wild-type mice at Day 3 after bleomycin challenge, as was lung caspase-3 activity. Consistent with these in vivo results, we found that LPA signaling through LPA(1) induced apoptosis in normal human bronchial epithelial cells in culture. LPA-LPA(1) signaling appeared to specifically mediate anoikis, the apoptosis of anchorage-dependent cells induced by their detachment. Similarly, LPA negatively regulated attachment of R3/1 rat alveolar epithelial cell line cells. In contrast, LPA signaling through LPA(1) promoted the resistance of lung fibroblasts to apoptosis, which has also been implicated in IPF. The ability of LPA-LPA(1) signaling to promote epithelial cell apoptosis and fibroblast resistance to apoptosis may therefore contribute to the capacity of this signaling pathway to regulate the development of pulmonary fibrosis after lung injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22021336      PMCID: PMC3326436          DOI: 10.1165/rcmb.2010-0155OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  49 in total

1.  Expression of apoptosis-regulatory genes in epithelial cells in pulmonary fibrosis in mice.

Authors:  K Kuwano; N Hagimoto; T Tanaka; M Kawasaki; R Kunitake; H Miyazaki; Y Kaneko; T Matsuba; T Maeyama; N Hara
Journal:  J Pathol       Date:  2000-02       Impact factor: 7.996

2.  Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner.

Authors:  T Furui; R LaPushin; M Mao; H Khan; S R Watt; M A Watt; Y Lu; X Fang; S Tsutsui; Z H Siddik; R C Bast; G B Mills
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

Review 3.  Apoptosis and extracellular matrix-cell interactions in kidney disease.

Authors:  H Makino; H Sugiyama; N Kashihara
Journal:  Kidney Int Suppl       Date:  2000-09       Impact factor: 10.545

4.  Inhibition of myofibroblast apoptosis by transforming growth factor beta(1).

Authors:  H Y Zhang; S H Phan
Journal:  Am J Respir Cell Mol Biol       Date:  1999-12       Impact factor: 6.914

5.  Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist.

Authors:  J S Swaney; C Chapman; L D Correa; K J Stebbins; A R Broadhead; G Bain; A M Santini; J Darlington; C D King; C S Baccei; C Lee; T A Parr; J R Roppe; T J Seiders; J Ziff; P Prasit; J H Hutchinson; J F Evans; D S Lorrain
Journal:  J Pharmacol Exp Ther       Date:  2010-12-15       Impact factor: 4.030

6.  Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinase.

Authors:  X Fang; S Yu; R LaPushin; Y Lu; T Furui; L Z Penn; D Stokoe; J R Erickson; R C Bast; G B Mills
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

7.  Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior.

Authors:  J J Contos; N Fukushima; J A Weiner; D Kaushal; J Chun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

Review 8.  Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy.

Authors:  M Selman; T E King; A Pardo
Journal:  Ann Intern Med       Date:  2001-01-16       Impact factor: 25.391

9.  Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E.

Authors:  Z Borok; A Gillissen; R Buhl; R F Hoyt; R C Hubbard; T Ozaki; S I Rennard; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1991-11

10.  Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis.

Authors:  Toby M Maher; Iona C Evans; Stephen E Bottoms; Paul F Mercer; Andrew J Thorley; Andrew G Nicholson; Geoffrey J Laurent; Teresa D Tetley; Rachel C Chambers; Robin J McAnulty
Journal:  Am J Respir Crit Care Med       Date:  2010-03-04       Impact factor: 21.405

View more
  48 in total

Review 1.  The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis.

Authors:  Rachel S Knipe; Andrew M Tager; James K Liao
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

2.  Fibrogenic Lung Injury Induces Non-Cell-Autonomous Fibroblast Invasion.

Authors:  Neil Ahluwalia; Paula E Grasberger; Brian M Mugo; Carol Feghali-Bostwick; Annie Pardo; Moisés Selman; David Lagares; Andrew M Tager
Journal:  Am J Respir Cell Mol Biol       Date:  2016-06       Impact factor: 6.914

Review 3.  New therapeutics based on emerging concepts in pulmonary fibrosis.

Authors:  Vishwaraj Sontake; Prathibha R Gajjala; Rajesh K Kasam; Satish K Madala
Journal:  Expert Opin Ther Targets       Date:  2018-11-28       Impact factor: 6.902

4.  Autotaxin emerges as a therapeutic target for idiopathic pulmonary fibrosis: limiting fibrosis by limiting lysophosphatidic acid synthesis.

Authors:  Andrew M Tager
Journal:  Am J Respir Cell Mol Biol       Date:  2012-11       Impact factor: 6.914

5.  Lysophosphatidic acid signaling through its receptor initiates profibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor.

Authors:  Norihiko Sakai; Jerold Chun; Jeremy S Duffield; David Lagares; Takashi Wada; Andrew D Luster; Andrew M Tager
Journal:  Kidney Int       Date:  2016-12-04       Impact factor: 10.612

6.  Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice.

Authors:  Long Shuang Huang; Panfeng Fu; Priya Patel; Anantha Harijith; Tianjiao Sun; Yutong Zhao; Joe G N Garcia; Jerold Chun; Viswanathan Natarajan
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

Review 7.  Lysophosphatidic acid (LPA) and its receptors: role in airway inflammation and remodeling.

Authors:  Yutong Zhao; Viswanathan Natarajan
Journal:  Biochim Biophys Acta       Date:  2012-07-15

Review 8.  Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis.

Authors:  Barry S Shea; Andrew M Tager
Journal:  Proc Am Thorac Soc       Date:  2012-07

9.  The mitochondrial cardiolipin remodeling enzyme lysocardiolipin acyltransferase is a novel target in pulmonary fibrosis.

Authors:  Long Shuang Huang; Biji Mathew; Haiquan Li; Yutong Zhao; Shwu-Fan Ma; Imre Noth; Sekhar P Reddy; Anantha Harijith; Peter V Usatyuk; Evgeny V Berdyshev; Naftali Kaminski; Tong Zhou; Wei Zhang; Yanmin Zhang; Jalees Rehman; Sainath R Kotha; Travis O Gurney; Narasimham L Parinandi; Yves A Lussier; Joe G N Garcia; Viswanathan Natarajan
Journal:  Am J Respir Crit Care Med       Date:  2014-06-01       Impact factor: 21.405

10.  Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis.

Authors:  Long Shuang Huang; Evgeny Berdyshev; Biji Mathew; Panfeng Fu; Irina A Gorshkova; Donghong He; Wenli Ma; Imre Noth; Shwu-Fan Ma; Srikanth Pendyala; Sekhar P Reddy; Tong Zhou; Wei Zhang; Steven A Garzon; Joe G N Garcia; Viswanathan Natarajan
Journal:  FASEB J       Date:  2013-01-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.